CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULOPATHY

Authors

  • Noer Hassianni Mercy L. Tobing
  • Agus Yudha Wijaya
  • Christina Aritonang
  • Yoyok Hendro

DOI:

https://doi.org/10.37304/jkupr.v9i1.2865

Keywords:

CIDP, Gangguan Imune Mediate yang didapat, Jarang, Kasus sulit, Terapi jamgka panjang

Abstract

Chornic inflammatory demyelinating polyradiculoneuropathy (CIDP) it is an disease of immune-mediated neuropathy (neuropathy due to immunological disorders), rare, the disease that can take many forms (heterogeneous), but treatable,. For much of 20th centuries the
introduction of CIDP has been limited so that it is referred to under different disease names.
Clinical and histopathologic descriptions are often confused with a disease-like appearance such as Guillain-Barre 'syndrome. To diagnose CIDP, it is necessary to perform an eletromyography (EMG) examination to assess the velocity of nerve conduction and this is an definite diagnostic test. Neural ultrasound and MRI can also help in diagnosis. CIDP is divided into two types, namely typical CIDP and atypical variants of CIDP. Atypical variants of CIDP with different phenotypes present a diagnostic challenge.

Downloads

Download data is not yet available.

References

Broers MC, Buncshoten C, Nieboer D, Lingsma HF, Jacobs, Incidence and

Prevalence of Chronic Inflammatory Demyelinating Polyradiculopathy: a

Systemic Review and Meta-Analysis, Neuroepidemiology 2019; 52: 161-72.

Mahdi-Rogers M, Hughes RAC. Epidemiology od Chronic Infalmmatory

Neuropathies in Southeast England. Eur J Neurol 2014; 21: 28-33.

Harris W, Newcomb WD. A Case of Relapsing Interstitial Hypertropic

Polyneuritis. Brain. 1929; 52: 108-116.

Van den Bergh PY, Hadden RD, Bouche P, et al. EuropeanFederation of

Neurological Societies/Peripheral Nerve Societyguideline on management of

chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint

task force of the EuropeanFederation of Neurological Societies and the Peripheral NerveSociety – first revision. Eur J Neurol2010; 17: 356–63.

Allen JA, Lewis RA. CIDP diagnostic pitfalls and perception oftreatment benefit. Neurology 2015; 85: 498–504.

Goedee HS, Van Der Pol WL, Van Asseldonk JTH, et al. Diagnosticvalue of sonography in treatment-naive chronic inflammatoryneuropathies. Neurology

; 88: 143–51.

Kieseier BC, Mathey EK, Sommer C, Hartung HP.Immune-mediated neuropathies. Nat Rev Dis Primers 2018; 4: 31.

Carina B., Bart C. J, Peter Y. K. V, David R. C, Pieter A. V, Progress in Diagnosis and Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Lancet Neural, Vol : 18, 2019.

Suraj. A. M, Praful K, Gareth J. P, Treatment of Chronic Inflammatory

Demyelinating Polyneuropathy With Pulsed Oral Steroid, American Medical Association, Vol : 65, 2008.

Ted M. B, Chronic Inflammatory Demyelinating Polyradiculoneuropathy,

History of Neurology : Seminal Citation, University of Virginia Department of

Neurology, Vol : 61, 2004

Downloads

Published

2021-04-22

How to Cite

Hassianni Mercy L. Tobing, N., Yudha Wijaya, A., Aritonang, C., & Hendro, Y. (2021). CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULOPATHY. Jurnal Kedokteran Universitas Palangka Raya, 9(1), 1257–1264. https://doi.org/10.37304/jkupr.v9i1.2865